All great partnerships start with a hi. Contact us today and let's grow your businesses together.
- Jill Rowley, Chief Growth Officer at Marketo
Neura intelligently transforms customer engagement by delivering live, actionable insights based on each user’s real-world behavior. Neura intelligently segments your audience based on each user’s unique lifestyle and behavioral traits. Send gaming notifications to “Morning Commuters” as they get on the train and tailor specific campaigns to Fitness Enthusiasts, Hard Workers, and users that are Sleep Deprived. Because web traffic, age, gender, and location are only part of the story.
Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy. Celling is fulfilling the promise that autologous cell therapy will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.
Technologies developed by Celling Biosciences collect, process and deliver autologous cells to the patient at the point of care. The use of the patient’s own cells to promote healing provides a way of accelerating the body’s natural healing process.
BennuLife is the leading provider of FDA-approved stem cell therapies designed to address a wide range of symptoms. Their team is made up of doctors, surgeons, scientists, researchers and clinicians who come together to bring cutting-edge expertise in orthopedic medicine, aesthetic rejuvenation, and general wellness directed at whole-body health.
Thermi is a global leader in advanced temperature-controlled radiofrequency technology. Thermi systems offer versatile modalities and safely deliver rapid results through controlled heating using RF to impact positive tissue change and naturally stimulate collagen. Clinicians use Thermi technology to help address common signs of aging and/or weight loss, which may include fine lines, post-baby body, cellulite, loose skin and tissue laxity, and empower people to take control over their skin, body and life.
LogDNA empowers organizations with a fast, scalable, secure way to centralize machine data, gain real-time insights, and pinpoint issues. With frustration-free setup, user-intuitive dashboards, and flexible deployment across cloud, multi-cloud, on-prem, and bare metal, LogDNA provides the exact logging tools your team needs, so they can focus on what they do best - build great products.
A continuous integration, continuous deployment, and user feedback platform for iOS and Android development teams. Acquired by Apple in January 2018.
Founded in 2014 by a mix of seasoned entrepreneurs, former security and intelligence specialists, and killer product developers, TruSTAR is focused on building the best threat intelligence platform for enterprise cybersecurity.
Founded in 2014 with the mission of conducting high-impact AI research and engineering in service of the common good. AI2 is the creation of Paul Allen, Microsoft co-founder, and is led by Dr. Oren Etzioni, a leading AI researcher. Situated on the shores of Lake Union, AI2 employs over 100 of the world’s best scientific and engineering talent in the field of AI, attracting individuals of varied interests and backgrounds from across the globe. AI2 prides itself on the diversity and collaboration of its team and takes a results-oriented approach to complex challenges in AI.
A hosted background job solution that lets you run your containers with dynamic scale, detailed analytics and world class customer support. Run short lived containers quickly, or even containers needing to work across multiple days. Whether it's a one-off job, or one that needs 1000's of workers running in parallel, we've got you covered. Acquired by Xenon Ventures in May 2017.
Vestaboard is an internet-connected mechanical display that merges the classic clattering flaps of a retro train board with modern internet technology. It displays messages automatically through channels you subscribe to or create for yourself. You can also send individual messages on-the-go. Vestaboard receives the message information via wi-fi, and flips the characters to the proper letters or numbers to show exactly what you want to see.
Founded in 2014, x.ai is a hardcore technology company with a mission to democratize the personal assistant. We’ve created Amy and Andrew Ingram, autonomous AI assistants who schedule meetings for you.
DealRoom assembled a superior team of M&A professionals, data scientists, programmers, engineers and ex-government officials. They have spent 500+ hours collaborating with our community of M&A experts across every Fortune list imaginable. Their experience allows them to understand the experience, as they have been a part of all phases of the deal, from sourcing to the final phases of integration.
Professional Skateboarder Jamie Thomas, founder of Zero Skateboards and Fallen Footwear, created STRAYE Footwear with the mission statement of "Straye-ing" from the mainstream and creating footwear for skaters, made by skaters.
As a consulting group, Day1 will help guide investment banks and corporations to navigate the M&A lifecycle with skill and efficiency, reducing time and effort spent while simultaneously maximizing value on both sides of the deal. Day1 not only view the deal from a holistic, objective viewpoint, finding opportunities to reduce work and increase insights along the way, but also integrate technology to support continuous innovation.
PicMonkey helps people and businesses stand out in a sea of sameness with impactful visuals that tell their brand story. They create image editing tools that truly get what it means to compete across digital and real-life domains with flexibility, collaboration, and rapid iteration.
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care.